Результаты исследований: Научные публикации в периодических изданиях › обзорная статья › Рецензирование
Anesthesia and intensive care in massive obstetric haemorrhage. Clinical guidelines (Treatment protocol). / Shifman, E. M.; Kulikov, A. V.; Protsenko, D. N. и др.
в: Voprosy Ginekologii, Akusherstva i Perinatologii, Том 17, № 3, 01.01.2018, стр. 81-100.Результаты исследований: Научные публикации в периодических изданиях › обзорная статья › Рецензирование
}
TY - JOUR
T1 - Anesthesia and intensive care in massive obstetric haemorrhage. Clinical guidelines (Treatment protocol)
AU - Shifman, E. M.
AU - Kulikov, A. V.
AU - Protsenko, D. N.
AU - Ovezov, A. M.
AU - Zabolotskikh, I. B.
AU - Artymuk, N. V.
AU - Belokrinitskaya, T. E.
AU - Penzhoyan, G. A.
AU - Bratishchev, I. V.
AU - Drobinskaya, A. N.
AU - Sitkin, S. I.
AU - Ronenson, A. M.
AU - Raspopin, Yu S.
AU - Matkovskiy, A. A.
AU - Ryazanova, O. V.
AU - Blauman, S. I.
AU - Shvechkova, M. V.
AU - Abazova, I. S.
AU - Kitiashvili, I. Z.
AU - Bukhtin, A. A.
AU - Gorokhovskiy, V. S.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - The article highlights the main provisions of the clinical guidelines (treatment protocols) on anaesthesia and intensive care in massive obstetric hemorrhage. It consistently presents main risk factors, possible complications (DIC-syndrome), principles of clinical and laboratory diagnosis of this pathology. Special attention is paid to the issues of infusion, transfusion therapy and correction of coagolopathic disorders. The problems of estimating the volume of blood loss, diagnosis of hemostasis system disorders, and hemodynamic regulation in hemorrhagic shock are discussed. The use of recombinant blood coagulation factor (FVIIa) in coagulopathy against the background of massive blood loss has been substantiated.
AB - The article highlights the main provisions of the clinical guidelines (treatment protocols) on anaesthesia and intensive care in massive obstetric hemorrhage. It consistently presents main risk factors, possible complications (DIC-syndrome), principles of clinical and laboratory diagnosis of this pathology. Special attention is paid to the issues of infusion, transfusion therapy and correction of coagolopathic disorders. The problems of estimating the volume of blood loss, diagnosis of hemostasis system disorders, and hemodynamic regulation in hemorrhagic shock are discussed. The use of recombinant blood coagulation factor (FVIIa) in coagulopathy against the background of massive blood loss has been substantiated.
KW - DIC-syndrome
KW - Hemostatic therapy
KW - Infusion therapy
KW - Massive hemorrhage
KW - Obstetrics
KW - Shock
UR - http://www.scopus.com/inward/record.url?scp=85052540370&partnerID=8YFLogxK
U2 - 10.20953/1726-1678-2018-3-81-100
DO - 10.20953/1726-1678-2018-3-81-100
M3 - Review article
AN - SCOPUS:85052540370
VL - 17
SP - 81
EP - 100
JO - Voprosy Ginekologii, Akusherstva i Perinatologii
JF - Voprosy Ginekologii, Akusherstva i Perinatologii
SN - 1726-1678
IS - 3
ER -
ID: 16337065